[Federal Register Volume 66, Number 32 (Thursday, February 15, 2001)]
[Notices]
[Page 10505]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 01-3815]


=======================================================================
-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

Office of the Secretary


White House Commission on Complementary and Alternative Medicine 
Policy; Notice of Meeting

    Pursuant to Section 10(d) of the Federal Advisory Committee Act, as 
amended (5 U.S.C. Appendix 2), notice is given of a meeting of the 
White House Commission on Complementary and Alternative Medicine 
Policy.
    The purpose of the meeting is to convene the Commission for a 
public hearing to receive public testimony for individuals and 
organizations interested in the subject of Federal policy regarding 
complementary and alternative medicine. The major focus of the meeting 
is on the education, training, and licensing and credentialing of all 
health care practitioners engaged in the delivery of complementary and 
alternative medicine (CAM) practices and products. Comments received at 
the meeting may be used by the Commission to prepare the Report to the 
President as required by the Executive Order.
    Comments should focus on the education and training of health care 
practitioners in complementary and alternative medicine. Invited 
speaker discussions include the following: Establishing CAM educational 
and training programs; Continuing CAM education and training; Assuring 
quality and accountability in CAM practice; and Credentialing and 
licensing of CAM practice. The discussion also may focus on the 
following questions:
    (1) Can uniform standards of education, training, licensing, and 
certification be applied to all practitioners?
    (2) What training and education should be required of all 
practitioners to assure access to safe and effective CAM practices and 
products?
    (3) What sources of funds exist for the education and training of 
all practitioners delivery of CAM practices and products?
    (4) Are performance standards or practice guidelines needed to 
assure the public will have access to the full range of safe and 
effective CAM practices and products?
    Some Commission members may participate by telephone conference. 
Opportunities for oral statements by the public will be provided on 
February 23, from about 4 p.m.-5:30 p.m. (Time approximate).

    Name of Committee: The White House Commission on Complementary 
and Alternative Medicine Policy.
    Date: February 22--23, 2001.
    Time: February 22--8:15 a.m.-5:45 p.m. February 23--8:15 a.m.-
5:30 p.m.
    Place: Hubert H. Humphrey Building, Room 800, 200 Independence 
Avenue, SW., Washington, DC 20201.
    Contact Persons: Michele M. Chang, CMT, MPH, Executive 
Secretary, or, Stephen C. Groft, Pharm.D., Executive Director, 6701 
Rockledge Drive, Room 1010, MSC 7707, Bethesda, MD 20817-7707, 
Phone: (301) 435-7592, Fax: (301) 480-1691, E-mail: 
[email protected].
    Because of the need to obtain the views of the public on these 
issues as soon as possible and because of the early deadline for the 
report required of the Commission, this notice is being provided at the 
earliest possible time.

SUPPLEMENTARY INFORMATION: The President established the White House 
Commission on Complementary and Alternative Medicine Policy on March 7, 
2000, by Executive Order 13147. The mission of the White House 
Commission on Complementary and Alternative Medicine Policy is to 
provide a report, through the Secretary of the Department of Health and 
Human Services, on legislative and administrative recommendations for 
assuring that public policy maximizes the benefits of complementary and 
alternative medicine to Americans.

Public Participation

    The meeting is open to the public with attendance limited by the 
availability of space on a first come first serve basis. Members of the 
public who wish to present oral comment may register no later than 
February 19, 2001, by completing the on-line registration form at the 
Commission's website or faxing a request to 301-480-1691. Additional 
information, including agenda item topics, for the meeting can be found 
on the website of the Commission at http://whccamp.hhs.gov.
    Oral comments will be limited to three minutes. Individuals who 
register to speak will be assigned in the order in which they 
registered. Due to time constraints, only one representative from each 
organization will be allotted time for oral testimony. The number of 
speakers and the time allotted may also be limited by the number of 
registrants. All requests to register should include the name, address, 
telephone number, and business or professional affiliation of the 
interested party, and should indicate the area of interest or question 
(as described above) to be addressed.
    Any person attending the meeting who has not registered to speak in 
advance of the meeting will be allowed to make a brief oral statement 
during the time set aside for public comment if time permits, and at 
the Chairperson's discretion. Individuals unable to attend the meeting, 
or any interested parties, may send written comments by mail, fax, or 
electronically to the staff office of the Commission for inclusion in 
the public record.
    When mailing or faxing written comments provide, if possible, an 
electronic version on diskette. Persons needing special assistance, 
such as sign language interpretation or other special accommodations, 
should contact the Commission staff at the address or telephone number 
listed no later than February 16, 2001.


    Dated: February 8, 2001.
LaVerne Y. Stringfield,
Director, Office of Federal Advisory Committee Policy.
[FR Doc. 01-3815 Filed 2-14-01; 8:45 am]
BILLING CODE 4140-01-M